Skin HealthRegeneration

GHK-Cu

Copper tripeptide for genomic reset, skin repair, and wound healing

Overview

GHK-Cu (Copper Tripeptide-1) is a naturally occurring human tripeptide complex renowned for its broad regenerative and genomic effects. Originally isolated from plasma, it acts as a copper-delivery system that declines with age. It is extensively studied for its ability to reset gene expression to a 'youthful' state, accelerate wound healing, and stimulate collagen production. Supplied as a lyophilized blue powder for research.

Chemical Information

IUPAC Name
Copper(II)-Glycyl-L-histidyl-L-lysine
Sequence
Gly-His-Lys (Cu2+ Complex)
Molecular Mass
404.9 Da
Formula
C14H22CuN6O4
GHK-Cu Chemical Structure

Mechanism of Action

Functions as a potent copper-delivery system and genomic modulator. Its high affinity for copper (Cu2+) allows it to activate critical copper-dependent enzymes like Lysyl Oxidase, which is essential for the cross-linking and maturation of collagen and elastin fibers. Crucially, transcriptomic studies reveal it acts as a 'master switch' for gene expression, resetting over 4,000 genes (approx. 30% of the genome) to a healthier, younger state. This includes the upregulation of DNA repair pathways and the downregulation of pro-inflammatory cytokines (TNF-α, IL-6) and metastatic genes. It also modulates Matrix Metalloproteinases (MMPs) and their inhibitors (TIMPs), preventing scar formation while promoting organized tissue remodeling.

Potential Research Fields

Genomic ReprogrammingWound HealingSkin RejuvenationLung FibrosisDNA Repair

Recent Research

Recent research (2024–2025) has elevated GHK-Cu from a cosmetic ingredient to a 'genomic stabilizer' with systemic potential. Studies utilizing the Broad Institute's Connectivity Map continue to confirm its ability to reverse the transcriptional signature of aging—specifically suppressing genes associated with metastasis (cancer spread) and inflammation while upregulating DNA repair pathways. New findings in 2024 highlight its potential in lung fibrosis and COPD, where GHK-Cu administration significantly reduced inflammatory cell infiltration and collagen deposition in alveolar tissue. Additionally, neurobiology research is investigating its role in protecting spinal cord tissue from oxidative damage by maintaining mitochondrial integrity.

Bibliography / Scientific References

Related Peptides

Peptide Information Guide
Administration Type
Injectable (Subcutaneous)

Injectable administration protocol for research.

Vial Strength
50mg100mg
Reconstitution
Reconstitute with 3ml bacteriostatic water
Dosage Options
1–2 mg
Daily
Standard systemic dose for anti-aging/repair
Schedule
1x daily
Timing: One specific day.
Duration
According to the Doctor
Potential Side Effects
Injection site pain (sting)
moderatecommon
Nausea (if zinc deficient)
lowrare
Research Use Only

This information is for research purposes only. Always consult with a healthcare professional before starting any peptide protocol. Individual responses may vary, and proper medical supervision is recommended for all peptide therapies.